Skip to content
ppharmaranks
Menu

LAMIVUDINE vs TENOFOVIR DISOPROXIL FUMARATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. LAMIVUDINE and TENOFOVIR DISOPROXIL FUMARATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

66/100
64/100

Pharmacy pays

$0.44 /mL
~$9.50 /30

Type

RX
RX

Active ingredient

LAMIVUDINE
TENOFOVIR DISOPROXIL FUMARATE

Manufacturer

Dosage forms

Tablet
Tablet

Drug class

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Boxed warning

Treats

Acquired Immunodeficiency Syndrome
Chronic Hepatitis B, Acquired Immunodeficiency Syndrome

Frequently asked questions

Which is better-rated, Lamivudine or Tenofovir Disoproxil Fumarate?

By our independent rating, Lamivudine scores higher — 3.3 vs 3.2 out of 5 for Tenofovir Disoproxil Fumarate. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Lamivudine and Tenofovir Disoproxil Fumarate?

Lamivudine contains Lamivudine, while Tenofovir Disoproxil Fumarate contains Tenofovir Disoproxil Fumarate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.